Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure: Editorial on “Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients”

Hae Lim Lee, Jeong Won Jang

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)692-694
Number of pages3
JournalClinical and Molecular Hepatology
Volume30
Issue number4
DOIs
StatePublished - Oct 2024

Keywords

  • Antiviral therapy
  • Core portein inhibitor
  • Functional cure
  • Hepatitis B virus

Cite this